The Capex Wave Transforming European Pharmaceutical Plants

European pharma plants are entering a major capex cycle. Discover why upgrades fail and how interim leadership stabilizes execution.
Why European Pharma Plants Are Entering a Modernisation Cycle

Why pharmaceutical plants across Europe are modernising and how companies manage complex upgrades without disrupting production.
EUDAMED 2026: Why Device Manufacturers Are Not Ready

EUDAMED becomes mandatory from 2026. Many MedTech manufacturers are not operationally ready for device data governance and UDI reporting.
MDR Transition Bottlenecks in EU MedTech Manufacturing

The MDR transition is stalling across Europe. Discover the operational bottlenecks slowing MedTech manufacturers & what companies must do.
Why Sterile Pharma Upgrades Fail Under EU Annex 1

EU Annex 1 is forcing major upgrades in sterile pharma plants. Discover why many remediation programs fail and where execution breaks down.
Poland Minimum Wage 2026: Operational Risk for Industry

Poland Minimum Wage 2026 raises more than payroll. How higher labor costs create operational risk for industry.
Operational Chaos in Polish Factories: Leadership Gap Risk

Operational chaos in Polish factories often signals a leadership gap. How drift erodes margins and how to restore execution discipline.
OTIF Failures in Poland Manufacturing: Turnaround Playbook

OTIF failures in Poland manufacturing can erode margin fast. A practical turnaround playbook to restore service and control.
E-Commerce Driven Manufacturing Risk in Poland

How Poland’s e-commerce growth is driving manufacturing volatility, margin leakage and working capital risk inside factories.
Automotive Footprint Shift to Poland: Execution Risk

Execution risks behind automotive footprint shifts to Poland and how ramp-up instability can erode margins if not tightly managed.
